Low-grade gliomas (LGGs) are a diverse group of primary brain tumors that often arise in young, otherwise healthy patients and generally have an indolent course with longerterm survival in comparison with high-grade gliomas. Treatment options include observation, surgery, radiation, chemotherapy, or a combined approach, and management is individualized based on tumor location, histology, molecular profile, and patient characteristics. Moreover, in this type of brain tumor with a relatively good prognosis and prolonged survival, the potential benefits of treatment must be carefully weighed against potential treatmentrelated risks.We review in this article current management strategies for LGG, including surgery, radiotherapy, and chemotherapy. In addition,the importance of profiling the genetic and molecular properties of LGGs in the development of targeted anticancer therapies is also reviewed. Finally, given the prevalence of these tumors in otherwise healthy young patients, the impact of treatment on neurocognitive function and quality of life is also evaluated. The Oncologist 2014;19:403-413Implications for Practice: This review summarizes the epidemiology, presentation, diagnosis, and treatment of low-grade gliomas. The article discusses recent advances in genetic characterization of these tumors, which has become particularly important in guiding tumor identification and classification, and may in some cases offer information about prognosis and/or expected response to treatment.The major studies regarding the use of radiation, chemotherapy, and surgical approaches in the treatment of these tumors are discussed.This information will aid medical oncologists in understanding the challenges inherent in diagnosing and treating patients with low-grade gliomas, and in recognizing the important factors to consider in devising treatment plans.